Introduction: Minimally invasive treatments (MITs) for benign prostatic hypertrophy are effective treatments in properly selected patients. Despite being minimally invasive, significant complications can still arise. The objective of this study is to describe a tertiary care center experience with complications arising from MITs for benign prostatic hyper-trophy. Patients and Methods: A retrospective chart review was done from January 2007 to August 2008 to identify patients who developed stress incontinence or a urethral stricture after undergoing a MIT for benign prostatic hyper-trophy. Results: Three patients were identified as experiencing a complication. All 3 patients had undergone a prior transurethral microwave thermotherapy procedure at 9, 14, and 13 months prior to presentation. No patients had prior pelvic radiation, bladder or urethral trauma. No patients had prostate cancer. Patient ages were 61, 71, and 90 years. One patient developed a urethral stricture without incontinence. The other 2 patients developed both stress incontinence as well as urethral strictures. Conclusions: MITs for benign prostatic hypertrophy are effective treatments in properly selected patients. Despite being minimally invasive, significant complications can still arise. Proper training and good surgical technique are required to minimize and avoid complications.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.